The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice
Renal fibrosis is an inevitable outcome of various manifestations of progressive chronic kidney diseases (CKD). The need for efficacious treatment regimen against renal fibrosis can therefore not be overemphasized. Here we show a novel protective role of Bacteroides fragilis ( B. fragilis ) in renal...
Saved in:
Published in | Nature communications Vol. 13; no. 1; pp. 6081 - 19 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
14.10.2022
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Renal fibrosis is an inevitable outcome of various manifestations of progressive chronic kidney diseases (CKD). The need for efficacious treatment regimen against renal fibrosis can therefore not be overemphasized. Here we show a novel protective role of
Bacteroides fragilis
(
B. fragilis
) in renal fibrosis in mice. We demonstrate decreased abundance of
B. fragilis
in the feces of CKD patients and unilateral ureteral obstruction (UUO) mice. Oral administration of live
B. fragilis
attenuates renal fibrosis in UUO and adenine mice models. Increased lipopolysaccharide (LPS) levels are decreased after
B. fragilis
administration. Results of metabolomics and proteomics studies show decreased level of 1,5-anhydroglucitol (1,5-AG), a substrate of SGLT2, which increases after
B. fragilis
administration via enhancement of renal SGLT2 expression. 1,5-AG is an agonist of TGR5 that attenuates renal fibrosis by inhibiting oxidative stress and inflammation. Madecassoside, a natural product found via in vitro screening promotes
B. fragilis
growth and remarkably ameliorates renal fibrosis. Our findings reveal the ameliorative role of B.
fragilis
in renal fibrosis via decreasing LPS and increasing 1,5-AG levels.
Renal fibrosis is the main pathological feature of chronic kidney disease (CKD). Here, the authors show that live B. fragilis can attenuate renal fibrosis via the upregulation of SGLT2, which contributes to renal reabsorption of 1,5-AG, and that 1,5-AG improves renal fibrosis via inhibition of oxidative stress and inflammation. |
---|---|
AbstractList | Renal fibrosis is an inevitable outcome of various manifestations of progressive chronic kidney diseases (CKD). The need for efficacious treatment regimen against renal fibrosis can therefore not be overemphasized. Here we show a novel protective role of
Bacteroides fragilis
(
B. fragilis
) in renal fibrosis in mice. We demonstrate decreased abundance of
B. fragilis
in the feces of CKD patients and unilateral ureteral obstruction (UUO) mice. Oral administration of live
B. fragilis
attenuates renal fibrosis in UUO and adenine mice models. Increased lipopolysaccharide (LPS) levels are decreased after
B. fragilis
administration. Results of metabolomics and proteomics studies show decreased level of 1,5-anhydroglucitol (1,5-AG), a substrate of SGLT2, which increases after
B. fragilis
administration via enhancement of renal SGLT2 expression. 1,5-AG is an agonist of TGR5 that attenuates renal fibrosis by inhibiting oxidative stress and inflammation. Madecassoside, a natural product found via in vitro screening promotes
B. fragilis
growth and remarkably ameliorates renal fibrosis. Our findings reveal the ameliorative role of B.
fragilis
in renal fibrosis via decreasing LPS and increasing 1,5-AG levels.
Renal fibrosis is the main pathological feature of chronic kidney disease (CKD). Here, the authors show that live B. fragilis can attenuate renal fibrosis via the upregulation of SGLT2, which contributes to renal reabsorption of 1,5-AG, and that 1,5-AG improves renal fibrosis via inhibition of oxidative stress and inflammation. Renal fibrosis is an inevitable outcome of various manifestations of progressive chronic kidney diseases (CKD). The need for efficacious treatment regimen against renal fibrosis can therefore not be overemphasized. Here we show a novel protective role of Bacteroides fragilis ( B. fragilis ) in renal fibrosis in mice. We demonstrate decreased abundance of B. fragilis in the feces of CKD patients and unilateral ureteral obstruction (UUO) mice. Oral administration of live B. fragilis attenuates renal fibrosis in UUO and adenine mice models. Increased lipopolysaccharide (LPS) levels are decreased after B. fragilis administration. Results of metabolomics and proteomics studies show decreased level of 1,5-anhydroglucitol (1,5-AG), a substrate of SGLT2, which increases after B. fragilis administration via enhancement of renal SGLT2 expression. 1,5-AG is an agonist of TGR5 that attenuates renal fibrosis by inhibiting oxidative stress and inflammation. Madecassoside, a natural product found via in vitro screening promotes B. fragilis growth and remarkably ameliorates renal fibrosis. Our findings reveal the ameliorative role of B. fragilis in renal fibrosis via decreasing LPS and increasing 1,5-AG levels. Renal fibrosis is an inevitable outcome of various manifestations of progressive chronic kidney diseases (CKD). The need for efficacious treatment regimen against renal fibrosis can therefore not be overemphasized. Here we show a novel protective role of Bacteroides fragilis (B. fragilis) in renal fibrosis in mice. We demonstrate decreased abundance of B. fragilis in the feces of CKD patients and unilateral ureteral obstruction (UUO) mice. Oral administration of live B. fragilis attenuates renal fibrosis in UUO and adenine mice models. Increased lipopolysaccharide (LPS) levels are decreased after B. fragilis administration. Results of metabolomics and proteomics studies show decreased level of 1,5-anhydroglucitol (1,5-AG), a substrate of SGLT2, which increases after B. fragilis administration via enhancement of renal SGLT2 expression. 1,5-AG is an agonist of TGR5 that attenuates renal fibrosis by inhibiting oxidative stress and inflammation. Madecassoside, a natural product found via in vitro screening promotes B. fragilis growth and remarkably ameliorates renal fibrosis. Our findings reveal the ameliorative role of B. fragilis in renal fibrosis via decreasing LPS and increasing 1,5-AG levels.Renal fibrosis is the main pathological feature of chronic kidney disease (CKD). Here, the authors show that live B. fragilis can attenuate renal fibrosis via the upregulation of SGLT2, which contributes to renal reabsorption of 1,5-AG, and that 1,5-AG improves renal fibrosis via inhibition of oxidative stress and inflammation. Renal fibrosis is an inevitable outcome of various manifestations of progressive chronic kidney diseases (CKD). The need for efficacious treatment regimen against renal fibrosis can therefore not be overemphasized. Here we show a novel protective role of Bacteroides fragilis (B. fragilis) in renal fibrosis in mice. We demonstrate decreased abundance of B. fragilis in the feces of CKD patients and unilateral ureteral obstruction (UUO) mice. Oral administration of live B. fragilis attenuates renal fibrosis in UUO and adenine mice models. Increased lipopolysaccharide (LPS) levels are decreased after B. fragilis administration. Results of metabolomics and proteomics studies show decreased level of 1,5-anhydroglucitol (1,5-AG), a substrate of SGLT2, which increases after B. fragilis administration via enhancement of renal SGLT2 expression. 1,5-AG is an agonist of TGR5 that attenuates renal fibrosis by inhibiting oxidative stress and inflammation. Madecassoside, a natural product found via in vitro screening promotes B. fragilis growth and remarkably ameliorates renal fibrosis. Our findings reveal the ameliorative role of B. fragilis in renal fibrosis via decreasing LPS and increasing 1,5-AG levels.Renal fibrosis is an inevitable outcome of various manifestations of progressive chronic kidney diseases (CKD). The need for efficacious treatment regimen against renal fibrosis can therefore not be overemphasized. Here we show a novel protective role of Bacteroides fragilis (B. fragilis) in renal fibrosis in mice. We demonstrate decreased abundance of B. fragilis in the feces of CKD patients and unilateral ureteral obstruction (UUO) mice. Oral administration of live B. fragilis attenuates renal fibrosis in UUO and adenine mice models. Increased lipopolysaccharide (LPS) levels are decreased after B. fragilis administration. Results of metabolomics and proteomics studies show decreased level of 1,5-anhydroglucitol (1,5-AG), a substrate of SGLT2, which increases after B. fragilis administration via enhancement of renal SGLT2 expression. 1,5-AG is an agonist of TGR5 that attenuates renal fibrosis by inhibiting oxidative stress and inflammation. Madecassoside, a natural product found via in vitro screening promotes B. fragilis growth and remarkably ameliorates renal fibrosis. Our findings reveal the ameliorative role of B. fragilis in renal fibrosis via decreasing LPS and increasing 1,5-AG levels. Renal fibrosis is the main pathological feature of chronic kidney disease (CKD). Here, the authors show that live B. fragilis can attenuate renal fibrosis via the upregulation of SGLT2, which contributes to renal reabsorption of 1,5-AG, and that 1,5-AG improves renal fibrosis via inhibition of oxidative stress and inflammation. Renal fibrosis is an inevitable outcome of various manifestations of progressive chronic kidney diseases (CKD). The need for efficacious treatment regimen against renal fibrosis can therefore not be overemphasized. Here we show a novel protective role of Bacteroides fragilis (B. fragilis) in renal fibrosis in mice. We demonstrate decreased abundance of B. fragilis in the feces of CKD patients and unilateral ureteral obstruction (UUO) mice. Oral administration of live B. fragilis attenuates renal fibrosis in UUO and adenine mice models. Increased lipopolysaccharide (LPS) levels are decreased after B. fragilis administration. Results of metabolomics and proteomics studies show decreased level of 1,5-anhydroglucitol (1,5-AG), a substrate of SGLT2, which increases after B. fragilis administration via enhancement of renal SGLT2 expression. 1,5-AG is an agonist of TGR5 that attenuates renal fibrosis by inhibiting oxidative stress and inflammation. Madecassoside, a natural product found via in vitro screening promotes B. fragilis growth and remarkably ameliorates renal fibrosis. Our findings reveal the ameliorative role of B. fragilis in renal fibrosis via decreasing LPS and increasing 1,5-AG levels. |
ArticleNumber | 6081 |
Author | Liu, Shi-jia Wang, Hanyu Zhang, Zhi-hao Jiang, Hong Li, Jing Zhou, Wei Shan, Jin-jun Bian, Xue-yan Liu, Hui-ling Wu, Wen-hui Tan, Ning-hua Si, Zi-lin Liu, Ya-fang Chen, Cheng Alolga, Raphael N. |
Author_xml | – sequence: 1 givenname: Wei orcidid: 0000-0001-5486-4849 surname: Zhou fullname: Zhou, Wei organization: State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University – sequence: 2 givenname: Wen-hui orcidid: 0000-0002-0336-6011 surname: Wu fullname: Wu, Wen-hui organization: State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University – sequence: 3 givenname: Zi-lin surname: Si fullname: Si, Zi-lin organization: State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University – sequence: 4 givenname: Hui-ling surname: Liu fullname: Liu, Hui-ling organization: State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University – sequence: 5 givenname: Hanyu surname: Wang fullname: Wang, Hanyu organization: State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University – sequence: 6 givenname: Hong surname: Jiang fullname: Jiang, Hong organization: State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University – sequence: 7 givenname: Ya-fang surname: Liu fullname: Liu, Ya-fang organization: State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University – sequence: 8 givenname: Raphael N. surname: Alolga fullname: Alolga, Raphael N. organization: State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University – sequence: 9 givenname: Cheng surname: Chen fullname: Chen, Cheng organization: Department of Nephrology, Renmin Hospital of Wuhan University – sequence: 10 givenname: Shi-jia surname: Liu fullname: Liu, Shi-jia organization: Affiliated Hospital of Nanjing University of Chinese Medicine – sequence: 11 givenname: Xue-yan surname: Bian fullname: Bian, Xue-yan organization: Ningbo Hospital of Zhejiang University – sequence: 12 givenname: Jin-jun surname: Shan fullname: Shan, Jin-jun organization: Medical Metabolomics Center, Nanjing University of Chinese Medicine – sequence: 13 givenname: Jing orcidid: 0000-0001-9972-7397 surname: Li fullname: Li, Jing organization: School of Life Science and Technology, China Pharmaceutical University – sequence: 14 givenname: Ning-hua surname: Tan fullname: Tan, Ning-hua email: nhtan@cpu.edu.cn organization: State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University – sequence: 15 givenname: Zhi-hao orcidid: 0000-0002-5152-0511 surname: Zhang fullname: Zhang, Zhi-hao email: zzh-198518@163.com organization: State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36241632$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UstO3TAUtBAVUMoPdFFF6qabtH7FTjaVCgKKhNQNXVt-HAdfJTG1EyT-vr430AILvLF1zsxo5Jn3aH-KEyD0keCvBLP2W-aEC1ljSmvGWsprsYeOKOakJpKy_WfvQ3SS8waXwzrScn6ADpmgnAhGj9DlzS1U_TJXY7ApGqhOtZ0hxeAgVz7pPgwhV3qEIcSk5zJMMOmh8sGkmMsqTFsqfEDvvB4ynDzex-j3xfnN2c_6-tfl1dmP69o2HM-1ccJ1WkgqhZVeSu077BviDG-pdmA0BykEx05ig7HhXAhiiYUCddh2jh2jq1XXRb1RdymMOj2oqIPaDWLqlU5zsAMoaVovJDjSdIybFuvWe9Nxb2WnsbNN0fq-at0tZgRnYZqTHl6IvtxM4Vb18V51jWgbJovAl0eBFP8skGc1hmxhGPQEccmKStqUGEo6Bfr5FXQTl1R-cofishOYbgU_PXf0z8pTXgXQroASVs4JvLJh1nOIW4NhUASrbTvU2g5V2qF27VCiUOkr6pP6myS2knIBTz2k_7bfYP0F5hLMOg |
CitedBy_id | crossref_primary_10_1097_IMNA_D_23_00017 crossref_primary_10_1039_D3FO05671F crossref_primary_10_1093_ckj_sfad303 crossref_primary_10_3390_app13053212 crossref_primary_10_1016_j_biopha_2023_115434 crossref_primary_10_1016_j_phymed_2024_156223 crossref_primary_10_1016_j_ijbiomac_2024_136492 crossref_primary_10_1016_j_phymed_2024_155372 crossref_primary_10_1097_TP_0000000000004485 crossref_primary_10_14336_AD_2023_0309 crossref_primary_10_1016_j_micres_2024_127796 crossref_primary_10_1021_acs_est_4c10724 crossref_primary_10_3389_fphar_2024_1456721 crossref_primary_10_1016_j_ijbiomac_2024_138629 crossref_primary_10_1097_IMNA_D_23_00012 crossref_primary_10_1111_jog_16236 crossref_primary_10_3390_nu15194198 crossref_primary_10_1016_j_jprot_2024_105355 crossref_primary_10_22246_jikm_2024_45_4_568 crossref_primary_10_1016_j_isci_2023_105991 crossref_primary_10_1089_met_2024_0030 crossref_primary_10_1016_j_ijbiomac_2024_134216 crossref_primary_10_1016_j_phymed_2024_156335 crossref_primary_10_1016_j_neuropharm_2023_109812 crossref_primary_10_1186_s40659_023_00431_8 crossref_primary_10_1016_j_foodres_2024_114322 crossref_primary_10_2147_IJNRD_S489074 crossref_primary_10_1007_s00018_024_05532_5 crossref_primary_10_1016_j_celrep_2023_112851 crossref_primary_10_3389_fcimb_2024_1523708 crossref_primary_10_1002_imt2_270 crossref_primary_10_1038_s41421_024_00709_5 crossref_primary_10_1038_s43705_023_00332_7 crossref_primary_10_23876_j_krcp_23_156 crossref_primary_10_3389_fcimb_2024_1363276 crossref_primary_10_1038_s42003_023_05581_9 crossref_primary_10_1039_D4FO03731F crossref_primary_10_1021_acs_jafc_4c02591 crossref_primary_10_1016_j_jff_2023_105469 crossref_primary_10_1002_advs_202307850 crossref_primary_10_1186_s40168_023_01734_4 crossref_primary_10_1002_advs_202406936 crossref_primary_10_1002_adma_202412783 crossref_primary_10_1038_s41598_024_59250_w crossref_primary_10_37349_edd_2023_00029 crossref_primary_10_1039_D3FO02110F crossref_primary_10_1016_j_lfs_2024_123072 crossref_primary_10_1186_s12951_024_02586_2 crossref_primary_10_1016_j_celrep_2024_114830 |
Cites_doi | 10.1038/nature08821 10.1038/nm.4358 10.1073/pnas.0400035101 10.1093/glycob/cwu117 10.1038/s41401-019-0319-4 10.1038/ki.2011.380 10.1002/hep.24525 10.1038/ismej.2015.131 10.1016/j.phymed.2019.153111 10.1053/j.ajkd.2014.01.416 10.1007/s10753-020-01382-y 10.2215/CJN.11971113 10.1128/am.27.5.961-979.1974 10.1136/bmj.k2179 10.1016/j.jep.2013.09.004 10.2337/dc12-0787 10.3389/fimmu.2020.609060 10.1038/s41586-021-03828-1 10.1038/srep22474 10.1016/j.phrs.2016.05.035 10.1038/nmeth.2834 10.1038/s41598-017-16635-4 10.1038/srep22151 10.1016/j.jpba.2020.113262 10.1038/nature07008 10.1373/clinchem.2012.188367 10.1111/bph.13421 10.1002/jcc.20290 10.1053/j.ajkd.2015.09.027 10.1146/annurev-physiol-022516-034227 10.1248/bpb.29.2432 10.3109/10715762.2013.779373 10.1681/ASN.2014121271 10.3390/toxins10070300 10.1126/science.8211161 10.1016/j.bbadis.2017.08.021 10.1038/s41581-018-0018-2 10.1038/srep18314 10.1126/science.abd8344 10.1016/j.jhep.2010.12.004 10.1038/mi.2010.29 10.1038/s41440-018-0144-z 10.1016/j.cell.2013.11.024 10.1038/ncomms8489 10.2133/dmpk.19.41 10.1002/ptr.5120 10.1161/HYPERTENSIONAHA.119.13079 10.1007/s00018-019-03155-9 10.1038/ki.2012.345 10.1128/mBio.02566-18 10.1016/j.cell.2005.05.007 10.1093/aje/kwx167 10.1007/s11306-020-1642-y 10.1007/978-1-4757-3230-6_13 10.1038/sj.onc.1209943 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B 10.1016/S0140-6736(13)60687-X 10.1681/ASN.2013080905 10.1021/pr1002214 10.1126/science.1206095 10.2337/diab.38.6.723 10.4049/jimmunol.1001443 10.2337/dc11-1462 10.1053/j.gastro.2019.03.020 10.1073/pnas.0909122107 10.1038/s41401-022-00898-3 |
ContentType | Journal Article |
Copyright | The Author(s) 2022 2022. The Author(s). The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM DOA |
DOI | 10.1038/s41467-022-33824-6 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Proquest Medical Database Biological Science Database Advanced Technologies & Aerospace Collection ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 19 |
ExternalDocumentID | oai_doaj_org_article_7b8f67ed15934b80a8ffb94fc79a0dc5 PMC9568537 36241632 10_1038_s41467_022_33824_6 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AARCD AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PKEHL PQEST PQUKI PRINS RC3 SOI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c540t-bd6d9a67276c7f77af90f51db482adeba4e76640d70b00b44661c1cef77d0c9d3 |
IEDL.DBID | C6C |
ISSN | 2041-1723 |
IngestDate | Wed Aug 27 01:27:22 EDT 2025 Thu Aug 21 18:39:58 EDT 2025 Thu Jul 10 23:30:50 EDT 2025 Wed Aug 13 09:29:02 EDT 2025 Mon Jul 21 05:36:48 EDT 2025 Tue Jul 01 00:58:28 EDT 2025 Thu Apr 24 23:04:15 EDT 2025 Fri Feb 21 02:38:18 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2022. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-bd6d9a67276c7f77af90f51db482adeba4e76640d70b00b44661c1cef77d0c9d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-9972-7397 0000-0002-5152-0511 0000-0001-5486-4849 0000-0002-0336-6011 |
OpenAccessLink | https://www.nature.com/articles/s41467-022-33824-6 |
PMID | 36241632 |
PQID | 2724796027 |
PQPubID | 546298 |
PageCount | 19 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_7b8f67ed15934b80a8ffb94fc79a0dc5 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9568537 proquest_miscellaneous_2725204824 proquest_journals_2724796027 pubmed_primary_36241632 crossref_citationtrail_10_1038_s41467_022_33824_6 crossref_primary_10_1038_s41467_022_33824_6 springer_journals_10_1038_s41467_022_33824_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-10-14 |
PublicationDateYYYYMMDD | 2022-10-14 |
PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-14 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature communications |
PublicationTitleAbbrev | Nat Commun |
PublicationTitleAlternate | Nat Commun |
PublicationYear | 2022 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Liu (CR24) 2017; 23 Wang (CR48) 2016; 27 Morris (CR69) 1998; 19 Zhou (CR31) 2016; 2 Juraschek, Steffes, Miller, Selvin (CR43) 2012; 35 Zhou (CR63) 2020; 185 Wang, Chen, Yu, Forman, Huang (CR49) 2011; 54 Cui (CR58) 2020; 66 Yamanouchi (CR42) 1989; 38 Turner, Bauer, Abramowitz, Melamed, Hostetter (CR5) 2012; 81 Kim (CR25) 2012; 35 Kulak, Pichler, Paron, Nagaraj, Mann (CR66) 2014; 11 Pluznick (CR6) 2020; 369 D’Argenio, Mazzacca (CR21) 1999; 472 Tunyasuvunakool (CR68) 2021; 596 Hashim (CR51) 2011; 18 Popolo (CR23) 2013; 47 Humphreys (CR3) 2018; 80 Moore We Fau, Holdeman, Holdeman (CR35) 1974; 27 Yamanouchi, Tachibana, Akanuma, Minoda, Akaoka (CR41) 1992; 263 Vaziri, Wong, Pahl, Piceno, Andersen (CR10) 2013; 83 Baxter (CR15) 2019; 10 Zhang (CR64) 2020; 16 Lu (CR55) 2014; 28 Round, Mazmanian (CR18) 2010; 107 Ramezani (CR14) 2016; 67 Park, Shin, Bae, Lee, Kim (CR32) 2006; 29 Ochoa-Repáraz (CR39) 2010; 185 Ochoa-Repáraz (CR36) 2010; 3 Qin (CR7) 2010; 464 Johnson, Jones, Cobb (CR20) 2015; 25 Nakamura, Masuda, Takahashi, Saito, Inui (CR46) 2004; 19 Rebholz Cm Fau (CR26) 2017; 186 Tzianabos, Onderdonk, Rosner, Cisneros, Kasper (CR16) 1993; 262 Pols, Noriega, Nomura, Auwerx, Schoonjans (CR27) 2011; 54 Li (CR65) 2019; 157 Yu (CR45) 2014; 9 Yang, Richards, Pepine, Raizada (CR9) 2018; 14 Zhang (CR62) 2016; 6 Chang (CR30) 2015; 23 Ramezani, Raj (CR34) 2013; 25 Inker (CR4) 2014; 63 Mazmanian, Round, Kasper, Kasper (CR17) 2008; 29 Castillo-Rodriguez (CR11) 2018; 10 Yang (CR28) 2016; 111 Zhuang (CR29) 2021; 44 Hayden, West, Ghosh (CR40) 2006; 25 Logue (CR59) 2016; 10 Feng (CR60) 2019; 76 Zhang, He, Zhao, Chen, Tan (CR22) 2020; 41 Juraschek, Steffes, Elizabeth (CR44) 2012; 58 Leng, Han, Rui, Dai, Xia (CR33) 2013; 150 Su, Ye, Qin, Ding (CR52) 2015; 5 Hsiao (CR19) 2013; 155 Humphreys (CR2) 2017; 7 Round (CR38) 2011; 332 Fukasawa (CR57) 2004; 101 Zhou, Hu, Tam (CR71) 2017; 7 Valdes, Walter, Segal, Spector (CR8) 2018; 361 Onal, Afsar, Covic, Vaziri, Kanbay (CR12) 2019; 42 Mazmanian (CR37) 2005; 122 Jha (CR1) 2013; 382 Salguero, Al-Obaide, Singh, Siepmann, Vasylyeva (CR13) 2019; 18 Wang (CR54) 2014; 12 Case (CR70) 2005; 26 Wiśniewski, Nagaraj, Zougman, Gnad, Mann (CR67) 2010; 9 CR61 Deutschmann (CR47) 2018; 1864 Marques (CR56) 2019; 74 Shi (CR50) 2020; 11 Xia (CR53) 2016; 173 JL Pluznick (33824_CR6) 2020; 369 MS Hayden (33824_CR40) 2006; 25 WJ Kim (33824_CR25) 2012; 35 SP Juraschek (33824_CR43) 2012; 35 DA Case (33824_CR70) 2005; 26 L Zhuang (33824_CR29) 2021; 44 J Ochoa-Repáraz (33824_CR39) 2010; 185 ND Vaziri (33824_CR10) 2013; 83 V Jha (33824_CR1) 2013; 382 JL Round (33824_CR38) 2011; 332 H Fukasawa (33824_CR57) 2004; 101 JL Johnson (33824_CR20) 2015; 25 TW Pols (33824_CR27) 2011; 54 LA Inker (33824_CR4) 2014; 63 W Zhou (33824_CR71) 2017; 7 GX Lu (33824_CR55) 2014; 28 SP Juraschek (33824_CR44) 2012; 58 K Deutschmann (33824_CR47) 2018; 1864 EM Onal (33824_CR12) 2019; 42 Moore We Fau (33824_CR35) 1974; 27 JR Wiśniewski (33824_CR67) 2010; 9 JM Turner (33824_CR5) 2012; 81 ZH Zhang (33824_CR22) 2020; 41 MV Salguero (33824_CR13) 2019; 18 J Qin (33824_CR7) 2010; 464 JB Logue (33824_CR59) 2016; 10 YD Wang (33824_CR49) 2011; 54 T Yang (33824_CR9) 2018; 14 W Zhou (33824_CR63) 2020; 185 E Castillo-Rodriguez (33824_CR11) 2018; 10 SK Mazmanian (33824_CR17) 2008; 29 P Hashim (33824_CR51) 2011; 18 GM Morris (33824_CR69) 1998; 19 Z Yang (33824_CR28) 2016; 111 D Cui (33824_CR58) 2020; 66 EK Park (33824_CR32) 2006; 29 AO Tzianabos (33824_CR16) 1993; 262 Z Su (33824_CR52) 2015; 5 Y Xia (33824_CR53) 2016; 173 J Li (33824_CR65) 2019; 157 JL Round (33824_CR18) 2010; 107 T Wang (33824_CR54) 2014; 12 G D’Argenio (33824_CR21) 1999; 472 BD Humphreys (33824_CR2) 2017; 7 DD Leng (33824_CR33) 2013; 150 Z Zhang (33824_CR64) 2020; 16 FZ Marques (33824_CR56) 2019; 74 NT Baxter (33824_CR15) 2019; 10 YL Feng (33824_CR60) 2019; 76 J Ochoa-Repáraz (33824_CR36) 2010; 3 A Popolo (33824_CR23) 2013; 47 N Nakamura (33824_CR46) 2004; 19 SK Mazmanian (33824_CR37) 2005; 122 R Liu (33824_CR24) 2017; 23 XX Wang (33824_CR48) 2016; 27 A Ramezani (33824_CR34) 2013; 25 T Yamanouchi (33824_CR41) 1992; 263 T Yamanouchi (33824_CR42) 1989; 38 B Yu (33824_CR45) 2014; 9 AM Valdes (33824_CR8) 2018; 361 A Ramezani (33824_CR14) 2016; 67 CJ Chang (33824_CR30) 2015; 23 ZH Zhang (33824_CR62) 2016; 6 Rebholz Cm Fau (33824_CR26) 2017; 186 NA Kulak (33824_CR66) 2014; 11 33824_CR61 K Tunyasuvunakool (33824_CR68) 2021; 596 SS Zhou (33824_CR31) 2016; 2 Y Shi (33824_CR50) 2020; 11 BD Humphreys (33824_CR3) 2018; 80 EY Hsiao (33824_CR19) 2013; 155 |
References_xml | – volume: 464 start-page: 59 year: 2010 end-page: 65 ident: CR7 article-title: A human gut microbial gene catalogue established by metagenomic sequencing publication-title: Nature doi: 10.1038/nature08821 – volume: 263 start-page: E268 year: 1992 ident: CR41 article-title: Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body publication-title: Am. J. Physiol. – volume: 23 start-page: 859 year: 2017 end-page: 868 ident: CR24 article-title: Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention publication-title: Nat. Med. doi: 10.1038/nm.4358 – volume: 101 start-page: 8687 year: 2004 end-page: 8692 ident: CR57 article-title: Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0400035101 – volume: 25 start-page: 368 year: 2015 end-page: 375 ident: CR20 article-title: Bacterial capsular polysaccharide prevents the onset of asthma through T-cell activation publication-title: Glycobiology doi: 10.1093/glycob/cwu117 – volume: 41 start-page: 373 year: 2020 end-page: 382 ident: CR22 article-title: Asiatic acid prevents renal fibrosis in UUO rats via promoting the production of 15d-PGJ2, an endogenous ligand of PPAR-γ publication-title: Acta Pharmacol. Sin. doi: 10.1038/s41401-019-0319-4 – volume: 81 start-page: 351 year: 2012 end-page: 362 ident: CR5 article-title: Treatment of chronic kidney disease publication-title: Kidney Int. doi: 10.1038/ki.2011.380 – volume: 54 start-page: 1421 year: 2011 end-page: 1432 ident: CR49 article-title: The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice publication-title: Hepatology doi: 10.1002/hep.24525 – volume: 10 start-page: 533 year: 2016 end-page: 545 ident: CR59 article-title: Experimental insights into the importance of aquatic bacterial community composition to the degradation of dissolved organic matter publication-title: ISME J. doi: 10.1038/ismej.2015.131 – volume: 66 start-page: 153111 year: 2020 ident: CR58 article-title: Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption publication-title: Phytomedicine doi: 10.1016/j.phymed.2019.153111 – volume: 7 start-page: 10 year: 2017 end-page: 17 ident: CR2 article-title: Mechanisms of renal fibrosis publication-title: Annu. Rev. Physiol. – volume: 63 start-page: 713 year: 2014 end-page: 735 ident: CR4 article-title: KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD publication-title: Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2014.01.416 – ident: CR61 – volume: 44 start-page: 859 year: 2021 end-page: 872 ident: CR29 article-title: TGR5 Attenuated liver ischemia-reperfusion injury by activating the Keap1-Nrf2 signaling pathway in mice publication-title: Inflammation doi: 10.1007/s10753-020-01382-y – volume: 9 start-page: 1410 year: 2014 end-page: 1417 ident: CR45 article-title: Serum metabolomic profiling and incident CKD among African Americans publication-title: Clin. J. Am. Soc. Nephrol. doi: 10.2215/CJN.11971113 – volume: 27 start-page: 961 year: 1974 end-page: 979 ident: CR35 article-title: Human fecal flora: the normal flora of 20 Japanese-Hawaiians publication-title: Appl. Microbiol. doi: 10.1128/am.27.5.961-979.1974 – volume: 361 start-page: k2179 year: 2018 ident: CR8 article-title: Role of the gut microbiota in nutrition and health publication-title: BMJ doi: 10.1136/bmj.k2179 – volume: 150 start-page: 601 year: 2013 end-page: 608 ident: CR33 article-title: In vivo disposition and metabolism of madecassoside, a major bioactive constituent in Centella asiatica (L.) Urb publication-title: J. Ethnopharmacol. doi: 10.1016/j.jep.2013.09.004 – volume: 35 start-page: 2265 year: 2012 end-page: 2270 ident: CR43 article-title: Alternative markers of hyperglycemia and risk of diabetes publication-title: Diabetes Care doi: 10.2337/dc12-0787 – volume: 11 start-page: 609060 year: 2020 ident: CR50 article-title: TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome Activation publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.609060 – volume: 596 start-page: 590 year: 2021 end-page: 596 ident: CR68 article-title: Highly accurate protein structure prediction for the human proteome publication-title: Nature doi: 10.1038/s41586-021-03828-1 – volume: 2 year: 2016 ident: CR31 article-title: Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction publication-title: Sci. Rep. doi: 10.1038/srep22474 – volume: 18 start-page: 3461 year: 2019 end-page: 3469 ident: CR13 article-title: Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease publication-title: Exp. Ther. Med. – volume: 111 start-page: 226 year: 2016 end-page: 236 ident: CR28 article-title: TGR5 activation suppressed S1P/S1P2 signaling and resisted high glucose-induced fibrosis in glomerular mesangial cells publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2016.05.035 – volume: 11 start-page: 319 year: 2014 end-page: 324 ident: CR66 article-title: Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells publication-title: Nat. Methods doi: 10.1038/nmeth.2834 – volume: 7 year: 2017 ident: CR71 article-title: Systemic clearance and brain distribution of carbazole-based cyanine compounds as Alzheimer’s disease drug candidates publication-title: Sci. Rep. doi: 10.1038/s41598-017-16635-4 – volume: 6 year: 2016 ident: CR62 article-title: An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure publication-title: Sci. Rep. doi: 10.1038/srep22151 – volume: 185 start-page: 113262 year: 2020 ident: CR63 article-title: Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2020.113262 – volume: 12 start-page: 943 year: 2014 end-page: 951 ident: CR54 article-title: A LC-ESI-MS method for the simultaneous determination of madecassoside and its metabolite madecassic acid in rat plasma: comparison pharmacokinetics in normal and collagen-induced arthritic rats publication-title: Chin. J. Nat. Med. – volume: 29 start-page: 620 year: 2008 end-page: 625 ident: CR17 article-title: A microbial symbiosis factor prevents intestinal inflammatory disease publication-title: Nature doi: 10.1038/nature07008 – volume: 58 start-page: 1648 year: 2012 end-page: 1655 ident: CR44 article-title: Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose publication-title: Clin. Chem. doi: 10.1373/clinchem.2012.188367 – volume: 18 start-page: 1215 year: 2011 end-page: 1222 ident: CR51 article-title: Centella asiatica in food and beverage applications and its potential antioxidant and neuroprotective effect publication-title: Int. Food Res. J. – volume: 173 start-page: 1219 year: 2016 end-page: 1235 ident: CR53 article-title: Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR- in colon publication-title: Br. J. Pharmacol. doi: 10.1111/bph.13421 – volume: 26 start-page: 1668 year: 2005 end-page: 1688 ident: CR70 article-title: The Amber biomolecular simulation programs publication-title: J. Comput. Chem. doi: 10.1002/jcc.20290 – volume: 67 start-page: 483 year: 2016 end-page: 498 ident: CR14 article-title: Role of the gut microbiome in uremia: a potential therapeutic target publication-title: Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2015.09.027 – volume: 80 start-page: 309 year: 2018 end-page: 326 ident: CR3 article-title: Mechanisms of renal fibrosis publication-title: Annu Rev. Physiol. doi: 10.1146/annurev-physiol-022516-034227 – volume: 29 start-page: 2432 year: 2006 end-page: 2435 ident: CR32 article-title: Intestinal bacteria activate estrogenic effect of main constituents puerarin and daidzin of Pueraria thunbergiana publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.29.2432 – volume: 47 start-page: 346 year: 2013 end-page: 356 ident: CR23 article-title: Oxidative stress in patients with cardiovascular disease and chronic renal failure publication-title: Free Radic. Res. doi: 10.3109/10715762.2013.779373 – volume: 27 start-page: 1362 year: 2016 end-page: 1378 ident: CR48 article-title: G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2014121271 – volume: 10 start-page: 300 year: 2018 ident: CR11 article-title: Impact of altered intestinal microbiota on chronic kidney disease progression publication-title: Toxins doi: 10.3390/toxins10070300 – volume: 262 start-page: 416 year: 1993 end-page: 419 ident: CR16 article-title: Structural features of polysaccharides that induce intra-abdominal abscesses publication-title: Science doi: 10.1126/science.8211161 – volume: 1864 start-page: 1319 year: 2018 end-page: 1325 ident: CR47 article-title: Bile acid receptors in the biliary tree: TGR5 in physiology and disease publication-title: Biochim Biophys. Acta Mol. Basis Dis. doi: 10.1016/j.bbadis.2017.08.021 – volume: 14 start-page: 442 year: 2018 end-page: 456 ident: CR9 article-title: The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease publication-title: Nat. Rev. Nephrol. doi: 10.1038/s41581-018-0018-2 – volume: 5 year: 2015 ident: CR52 article-title: Protective effects of madecassoside against doxorubicin induced nephrotoxicity in vivo and in vitro publication-title: Sci. Rep. doi: 10.1038/srep18314 – volume: 369 start-page: 1426 year: 2020 end-page: 1427 ident: CR6 article-title: The gut microbiota in kidney disease publication-title: Science doi: 10.1126/science.abd8344 – volume: 54 start-page: 1263 year: 2011 end-page: 1272 ident: CR27 article-title: The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation publication-title: J. Hepatol. doi: 10.1016/j.jhep.2010.12.004 – volume: 3 start-page: 487 year: 2010 end-page: 495 ident: CR36 article-title: A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease publication-title: Mucosal Immunol. doi: 10.1038/mi.2010.29 – volume: 42 start-page: 123 year: 2019 end-page: 140 ident: CR12 article-title: Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease publication-title: Hypertens. Res. doi: 10.1038/s41440-018-0144-z – volume: 155 start-page: 1451 year: 2013 end-page: 1463 ident: CR19 article-title: Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders publication-title: Cell doi: 10.1016/j.cell.2013.11.024 – volume: 23 year: 2015 ident: CR30 article-title: Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota publication-title: Nat. Commun. doi: 10.1038/ncomms8489 – volume: 19 start-page: 41 year: 2004 end-page: 47 ident: CR46 article-title: Decreased expression of glucose and peptide transporters in rat remnant kidney publication-title: Drug Metab. Pharmacokinet. doi: 10.2133/dmpk.19.41 – volume: 28 start-page: 1224 year: 2014 end-page: 1231 ident: CR55 article-title: Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice by downregulating collagen deposition publication-title: Phytother. Res. doi: 10.1002/ptr.5120 – volume: 74 start-page: 1279 year: 2019 end-page: 1293 ident: CR56 article-title: Guidelines for transparency on gut microbiome studies in essential and experimental hypertension publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.119.13079 – volume: 76 start-page: 4961 year: 2019 end-page: 4978 ident: CR60 article-title: Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease publication-title: Cell Mol. Life Sci. doi: 10.1007/s00018-019-03155-9 – volume: 83 start-page: 308 year: 2013 end-page: 315 ident: CR10 article-title: Chronic kidney disease alters intestinal microbial flora publication-title: Kidney Int. doi: 10.1038/ki.2012.345 – volume: 10 start-page: e02566 year: 2019 ident: CR15 article-title: Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers publication-title: mBio doi: 10.1128/mBio.02566-18 – volume: 122 start-page: 107 year: 2005 end-page: 118 ident: CR37 article-title: An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system publication-title: Cell doi: 10.1016/j.cell.2005.05.007 – volume: 186 start-page: 952 year: 2017 end-page: 960 ident: CR26 article-title: Serum levels of 1,5-anhydroglucitol and risk of incident end-stage renal disease publication-title: Am. J. Epidemiol. doi: 10.1093/aje/kwx167 – volume: 16 year: 2020 ident: CR64 article-title: Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome publication-title: Metabolomics doi: 10.1007/s11306-020-1642-y – volume: 472 start-page: 149 year: 1999 end-page: 158 ident: CR21 article-title: Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4757-3230-6_13 – volume: 25 start-page: 6758 year: 2006 end-page: 6780 ident: CR40 article-title: NF-κB and the immune response publication-title: Oncogene doi: 10.1038/sj.onc.1209943 – volume: 19 start-page: 1639 year: 1998 end-page: 1662 ident: CR69 article-title: Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function publication-title: J. Comput. Chem. doi: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B – volume: 382 start-page: 260 year: 2013 end-page: 272 ident: CR1 article-title: Chronic kidney disease: global dimension and perspectives publication-title: Lancet doi: 10.1016/S0140-6736(13)60687-X – volume: 25 start-page: 657 year: 2013 end-page: 670 ident: CR34 article-title: The gut microbiome, kidney disease, and targeted interventions publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2013080905 – volume: 9 start-page: 3280 year: 2010 end-page: 3289 ident: CR67 article-title: Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology publication-title: J. Proteome Res. doi: 10.1021/pr1002214 – volume: 332 start-page: 974 year: 2011 end-page: 977 ident: CR38 article-title: The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota publication-title: Science doi: 10.1126/science.1206095 – volume: 38 start-page: 723 year: 1989 end-page: 729 ident: CR42 article-title: Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients publication-title: Diabetes doi: 10.2337/diab.38.6.723 – volume: 185 start-page: 4101 year: 2010 end-page: 4108 ident: CR39 article-title: Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression publication-title: J. Immunol. doi: 10.4049/jimmunol.1001443 – volume: 35 start-page: 281 year: 2012 end-page: 286 ident: CR25 article-title: Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction publication-title: Diabetes Care doi: 10.2337/dc11-1462 – volume: 157 start-page: 257 year: 2019 end-page: 259.e255 ident: CR65 article-title: Tyrosine and glutamine-leucine are metabolic markers of early-stage colorectal cancers publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.03.020 – volume: 107 start-page: 12204 year: 2010 end-page: 12209 ident: CR18 article-title: Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0909122107 – volume: 6 year: 2016 ident: 33824_CR62 publication-title: Sci. Rep. doi: 10.1038/srep22151 – volume: 262 start-page: 416 year: 1993 ident: 33824_CR16 publication-title: Science doi: 10.1126/science.8211161 – volume: 66 start-page: 153111 year: 2020 ident: 33824_CR58 publication-title: Phytomedicine doi: 10.1016/j.phymed.2019.153111 – volume: 369 start-page: 1426 year: 2020 ident: 33824_CR6 publication-title: Science doi: 10.1126/science.abd8344 – volume: 25 start-page: 657 year: 2013 ident: 33824_CR34 publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2013080905 – volume: 173 start-page: 1219 year: 2016 ident: 33824_CR53 publication-title: Br. J. Pharmacol. doi: 10.1111/bph.13421 – volume: 10 start-page: 300 year: 2018 ident: 33824_CR11 publication-title: Toxins doi: 10.3390/toxins10070300 – volume: 101 start-page: 8687 year: 2004 ident: 33824_CR57 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0400035101 – ident: 33824_CR61 doi: 10.1038/s41401-022-00898-3 – volume: 185 start-page: 4101 year: 2010 ident: 33824_CR39 publication-title: J. Immunol. doi: 10.4049/jimmunol.1001443 – volume: 9 start-page: 3280 year: 2010 ident: 33824_CR67 publication-title: J. Proteome Res. doi: 10.1021/pr1002214 – volume: 76 start-page: 4961 year: 2019 ident: 33824_CR60 publication-title: Cell Mol. Life Sci. doi: 10.1007/s00018-019-03155-9 – volume: 7 year: 2017 ident: 33824_CR71 publication-title: Sci. Rep. doi: 10.1038/s41598-017-16635-4 – volume: 29 start-page: 2432 year: 2006 ident: 33824_CR32 publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.29.2432 – volume: 29 start-page: 620 year: 2008 ident: 33824_CR17 publication-title: Nature doi: 10.1038/nature07008 – volume: 54 start-page: 1421 year: 2011 ident: 33824_CR49 publication-title: Hepatology doi: 10.1002/hep.24525 – volume: 42 start-page: 123 year: 2019 ident: 33824_CR12 publication-title: Hypertens. Res. doi: 10.1038/s41440-018-0144-z – volume: 155 start-page: 1451 year: 2013 ident: 33824_CR19 publication-title: Cell doi: 10.1016/j.cell.2013.11.024 – volume: 26 start-page: 1668 year: 2005 ident: 33824_CR70 publication-title: J. Comput. Chem. doi: 10.1002/jcc.20290 – volume: 7 start-page: 10 year: 2017 ident: 33824_CR2 publication-title: Annu. Rev. Physiol. – volume: 27 start-page: 1362 year: 2016 ident: 33824_CR48 publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2014121271 – volume: 382 start-page: 260 year: 2013 ident: 33824_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(13)60687-X – volume: 185 start-page: 113262 year: 2020 ident: 33824_CR63 publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2020.113262 – volume: 150 start-page: 601 year: 2013 ident: 33824_CR33 publication-title: J. Ethnopharmacol. doi: 10.1016/j.jep.2013.09.004 – volume: 14 start-page: 442 year: 2018 ident: 33824_CR9 publication-title: Nat. Rev. Nephrol. doi: 10.1038/s41581-018-0018-2 – volume: 38 start-page: 723 year: 1989 ident: 33824_CR42 publication-title: Diabetes doi: 10.2337/diab.38.6.723 – volume: 25 start-page: 368 year: 2015 ident: 33824_CR20 publication-title: Glycobiology doi: 10.1093/glycob/cwu117 – volume: 472 start-page: 149 year: 1999 ident: 33824_CR21 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4757-3230-6_13 – volume: 18 start-page: 3461 year: 2019 ident: 33824_CR13 publication-title: Exp. Ther. Med. – volume: 9 start-page: 1410 year: 2014 ident: 33824_CR45 publication-title: Clin. J. Am. Soc. Nephrol. doi: 10.2215/CJN.11971113 – volume: 47 start-page: 346 year: 2013 ident: 33824_CR23 publication-title: Free Radic. Res. doi: 10.3109/10715762.2013.779373 – volume: 11 start-page: 319 year: 2014 ident: 33824_CR66 publication-title: Nat. Methods doi: 10.1038/nmeth.2834 – volume: 361 start-page: k2179 year: 2018 ident: 33824_CR8 publication-title: BMJ doi: 10.1136/bmj.k2179 – volume: 74 start-page: 1279 year: 2019 ident: 33824_CR56 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.119.13079 – volume: 19 start-page: 41 year: 2004 ident: 33824_CR46 publication-title: Drug Metab. Pharmacokinet. doi: 10.2133/dmpk.19.41 – volume: 41 start-page: 373 year: 2020 ident: 33824_CR22 publication-title: Acta Pharmacol. Sin. doi: 10.1038/s41401-019-0319-4 – volume: 10 start-page: 533 year: 2016 ident: 33824_CR59 publication-title: ISME J. doi: 10.1038/ismej.2015.131 – volume: 23 start-page: 859 year: 2017 ident: 33824_CR24 publication-title: Nat. Med. doi: 10.1038/nm.4358 – volume: 3 start-page: 487 year: 2010 ident: 33824_CR36 publication-title: Mucosal Immunol. doi: 10.1038/mi.2010.29 – volume: 11 start-page: 609060 year: 2020 ident: 33824_CR50 publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.609060 – volume: 80 start-page: 309 year: 2018 ident: 33824_CR3 publication-title: Annu Rev. Physiol. doi: 10.1146/annurev-physiol-022516-034227 – volume: 25 start-page: 6758 year: 2006 ident: 33824_CR40 publication-title: Oncogene doi: 10.1038/sj.onc.1209943 – volume: 332 start-page: 974 year: 2011 ident: 33824_CR38 publication-title: Science doi: 10.1126/science.1206095 – volume: 596 start-page: 590 year: 2021 ident: 33824_CR68 publication-title: Nature doi: 10.1038/s41586-021-03828-1 – volume: 35 start-page: 2265 year: 2012 ident: 33824_CR43 publication-title: Diabetes Care doi: 10.2337/dc12-0787 – volume: 67 start-page: 483 year: 2016 ident: 33824_CR14 publication-title: Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2015.09.027 – volume: 186 start-page: 952 year: 2017 ident: 33824_CR26 publication-title: Am. J. Epidemiol. doi: 10.1093/aje/kwx167 – volume: 27 start-page: 961 year: 1974 ident: 33824_CR35 publication-title: Appl. Microbiol. doi: 10.1128/am.27.5.961-979.1974 – volume: 18 start-page: 1215 year: 2011 ident: 33824_CR51 publication-title: Int. Food Res. J. – volume: 1864 start-page: 1319 year: 2018 ident: 33824_CR47 publication-title: Biochim Biophys. Acta Mol. Basis Dis. doi: 10.1016/j.bbadis.2017.08.021 – volume: 111 start-page: 226 year: 2016 ident: 33824_CR28 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2016.05.035 – volume: 2 year: 2016 ident: 33824_CR31 publication-title: Sci. Rep. doi: 10.1038/srep22474 – volume: 157 start-page: 257 year: 2019 ident: 33824_CR65 publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.03.020 – volume: 35 start-page: 281 year: 2012 ident: 33824_CR25 publication-title: Diabetes Care doi: 10.2337/dc11-1462 – volume: 81 start-page: 351 year: 2012 ident: 33824_CR5 publication-title: Kidney Int. doi: 10.1038/ki.2011.380 – volume: 464 start-page: 59 year: 2010 ident: 33824_CR7 publication-title: Nature doi: 10.1038/nature08821 – volume: 63 start-page: 713 year: 2014 ident: 33824_CR4 publication-title: Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2014.01.416 – volume: 263 start-page: E268 year: 1992 ident: 33824_CR41 publication-title: Am. J. Physiol. – volume: 54 start-page: 1263 year: 2011 ident: 33824_CR27 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2010.12.004 – volume: 44 start-page: 859 year: 2021 ident: 33824_CR29 publication-title: Inflammation doi: 10.1007/s10753-020-01382-y – volume: 107 start-page: 12204 year: 2010 ident: 33824_CR18 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0909122107 – volume: 23 year: 2015 ident: 33824_CR30 publication-title: Nat. Commun. doi: 10.1038/ncomms8489 – volume: 83 start-page: 308 year: 2013 ident: 33824_CR10 publication-title: Kidney Int. doi: 10.1038/ki.2012.345 – volume: 19 start-page: 1639 year: 1998 ident: 33824_CR69 publication-title: J. Comput. Chem. doi: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B – volume: 58 start-page: 1648 year: 2012 ident: 33824_CR44 publication-title: Clin. Chem. doi: 10.1373/clinchem.2012.188367 – volume: 10 start-page: e02566 year: 2019 ident: 33824_CR15 publication-title: mBio doi: 10.1128/mBio.02566-18 – volume: 5 year: 2015 ident: 33824_CR52 publication-title: Sci. Rep. doi: 10.1038/srep18314 – volume: 12 start-page: 943 year: 2014 ident: 33824_CR54 publication-title: Chin. J. Nat. Med. – volume: 28 start-page: 1224 year: 2014 ident: 33824_CR55 publication-title: Phytother. Res. doi: 10.1002/ptr.5120 – volume: 16 year: 2020 ident: 33824_CR64 publication-title: Metabolomics doi: 10.1007/s11306-020-1642-y – volume: 122 start-page: 107 year: 2005 ident: 33824_CR37 publication-title: Cell doi: 10.1016/j.cell.2005.05.007 |
SSID | ssj0000391844 |
Score | 2.599937 |
Snippet | Renal fibrosis is an inevitable outcome of various manifestations of progressive chronic kidney diseases (CKD). The need for efficacious treatment regimen... Renal fibrosis is the main pathological feature of chronic kidney disease (CKD). Here, the authors show that live B. fragilis can attenuate renal fibrosis via... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 6081 |
SubjectTerms | 13 38/77 631/326/2565/2134 64/60 692/699/1585/3182 82/58 Adenine Adenine - metabolism Animal models Animals Attenuation Bacteroides fragilis Biological Products - metabolism Disease Models, Animal Fibrosis Gastrointestinal Microbiome Humanities and Social Sciences Inflammation Kidney - metabolism Kidney diseases Kidney Diseases - pathology Kidneys Lipopolysaccharides Lipopolysaccharides - metabolism Lipopolysaccharides - toxicity Metabolomics Mice Microorganisms multidisciplinary Natural products Oral administration Oxidation Oxidative stress Proteomics Reabsorption Renal Insufficiency, Chronic - pathology Science Science (multidisciplinary) Sodium-Glucose Transporter 2 - metabolism Substrates Ureteral Obstruction - metabolism |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5VlZB6qSgUCC0oSNwgquM4dnKkiFIhwamVerP8bCNts2ize-DfM-Nkl27L48I1niTWPDwzmvE3AG9tkBZzH1eYkjUFWqJDm4umMHRcEr6dTGj7X7_J80vx5aq-ujPqi3rCRnjgkXEnyjZRquDR7VbCNsw0MdpWRKdaw7xL6KXo8-4kU-kMrlpMXcR0S4ZVzckg0pmQmterhotCbnmiBNj_uyjzYbPkvYppckRnj2F_iiDzD-POD2An9E_g0ThT8sdT-IyCz69Xy_yWWu1syE8THvO882HI48Jcd7NuyM1tmNHlfAw080Wg70XMm-cDLnU9vRoO4fLs08XH82KallA4jLqWhfXSt4YKq9KpqJSJLYt16a1ouPHBGhGUlIJ5xdDULNVxS1e6gKSeudZXz2C3n_fhBeQUQ8ZYM1tTQMekrVpLuG285sbUMmZQrjmn3QQlThMtZjqVtKtGj9zWyG2duK1lBu8273wfgTT-Sn1KAtlQEgh2eoCqoSfV0P9SjQyO1-LUk2UOmisuFKZtXGXwZrOMNkWFEtOH-SrR1ARozEUGz0fpb3aCDp9iWJ6B2tKLra1ur_TdTcLtppuZdYX_fb_WoF_b-jMrXv4PVhzBHifVp1YccQy7y8UqvMJoamlfJ8P5CVxnGak priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4t20BQWJG0R1HL9yQhRRKiQ4UWlvlp9LpG1SNrsH_j0ex5tqefQa24kz47E_e8bfIPTGeG7i3sdWusayipZoo80FXWmYLoHfjie2_a_f-MUl_bJgi3zgNuawyt2cmCZqN1g4Iz8lglAR4TYR769_VpA1CryrOYXGXXQPqMsgpEssxHzGAuznktJ8VwY38nSkaWZIIeyNJLTie-tRou3_F9b8O2TyD79pWo7OH6GHGUeWHybFP0Z3fP8E3Z8yS_56ij5H9ZfL7aa8goA748uzxMo8dM6PZVjrZbfqxlJf-RVc0Y9ws1x7eF-Iu-dhjEVdD039M3R5_un7x4sq50yobMRem8o47loN7lVuRRBChxYHVjtDJdHOG0294JxiJ3A0OAPe3NrW1seqDtvWNc_RQT_0_hCVgCRDYNgwgHWYm6Y1wN5GGNGa8VCgeic5ZTOhOOS1WKnk2G6kmqStorRVkrbiBXo7t7me6DRurX0GCplrAhV2ejCslypblhJGBi68i7isoUZiLUMwLQ1WtBo7ywp0slOnyvY5qpvRVKDXc3G0LHCX6N4P21SHAa0xoQV6MWl_7klc9gHJkgKJvXGx19X9kr77kdi74X4ma-J33-1G0E23_i-Ko9v_4hg9IDCoIdSGnqCDzXrrX0a0tDGvkkn8BkhGEDI priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9RAEG7WFcGL-Da6SgRvGk06_UgOIq64LsJ6cmBvTT9nA7OJJjPg_nurOsnI6Ch4TVcnTXVV-iuq-itCXhgvDMQ-NtNFXmXgiRZ8LuhM4-8S-e1EZNs_-yJOF-zzOT8_IHO7o0mBw97QDvtJLfrV6x_fr96Bw78dr4xXbwYW3T3WpZcVZZm4Rq7DySTRUc8muB__zGUNAQ2b7s7sn7pzPkUa_33Y888Syt_yqPF4OrlNbk24Mn0_GsIdcuDbu-TG2Gny6h75BOaQLjfr9BIL8IxPjyNLc9c4P6Sh18tm1QypvvQrvLIP8DPtPb4vQDTdDTDUtDjV3yeLk49fP5xmUw-FzAIWW2fGCVdrTLcKK4OUOtR54IUzrKLaeaOZl0Kw3MkcHNBgdrewhfUg6nJbu_IBOWy71j8iKSLLEHhuOMK8XJiyNsjmRjnVmouQkGLWnLITwTj2uVipmOguKzVqW4G2VdS2Egl5uZ3zbaTX-Kf0MW7IVhKpseODrl-qydOUNFUQ0jvAaSUzVa6rEEzNgpW1zp3lCTmat1PN5qaopExCMEdlQp5vh8HTMH2iW99togxHmmPKEvJw3P3tSgAGILKlCZE7drGz1N2RtrmIbN54X5OX8N1XswX9WtbfVfH4_8SfkJsUjRxLcdgROVz3G_8U0NTaPIsu8hM-8ReQ priority: 102 providerName: Scholars Portal |
Title | The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice |
URI | https://link.springer.com/article/10.1038/s41467-022-33824-6 https://www.ncbi.nlm.nih.gov/pubmed/36241632 https://www.proquest.com/docview/2724796027 https://www.proquest.com/docview/2725204824 https://pubmed.ncbi.nlm.nih.gov/PMC9568537 https://doaj.org/article/7b8f67ed15934b80a8ffb94fc79a0dc5 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEB_uA8EX8dvquVTwTYttmibp4-5ye8fCHaIe7FtJmmSvsNfKdvfB_95M-iGrp-BLC82kDZOZ5pfM5BeA98ow5eY-ZSSTWETOE0vnc1ZGEn-XyG_HPNv-1TW7vKHLVbY6AjLshfFJ-57S0v-mh-ywTy31Lu1zz1NBaMSO4RSp29Gq52w-rqsg47mgtN8fE6finqoHY5Cn6r8PX_6ZJvlbrNQPQYvH8KjHjuG0a-0TODL1U3jQnSb54xlcuC4P1_tdeIdJdsqEM8_E3FTatKHdynW1qdpQ3pkNbst3EDPcGnyfdTPmpnVFVY1VzXO4WZx_m19G_TkJUenw1i5SmulcYkiVldxyLm0e2yzRigoitVGSGs4YjTWPnZMpjOAmZVIaJ6rjMtfpCzipm9q8ghDRo7VZrDKEcjFTaa6QsY1kRMqM2QCSQXNF2ZOI41kWm8IHs1NRdNounLYLr-2CBfBhrPO9o9D4p_QMO2SURPpr_6DZroveHAquhGXcaIfFUqpELIW1Kqe25LmMdZkFcDZ0Z9H7ZFsQTih3EzbCA3g3FjtvwhCJrE2z9zIZUhkTGsDLrvfHlrihHtErCYAf2MVBUw9L6urWM3bjnswsdd_9OFjQr2b9XRWv_0_8DTwkaOSYbkPP4GS33Zu3DjHt1ASO-Yq7q1hcTOB0Ol1-Xbr77Pz685eJd5-JX4tw1ysqfgI6QRS0 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4k2gQJDgBFEdx7GTA0IUKFv6OLXS3oyfS6RtUja7Qv1T_EY8zqNaHr31GjuJM54Zf86Mv0HolbJM-b2PTmSKi8RbovY252QiwV0Cvx0LbPuHR2xyQr9O8-kG-jWchYG0ysEnBkdtGg3_yLcJJ5R7uE34-7MfCVSNgujqUEKjU4t9e_7Tb9nad3uf_Py-JmT38_HHSdJXFUi0RyfLRBlmSgkBSKa541y6Ers8NYoWRBqrJLWcMYoNx14lFcQ7U51q67sarEuT-edeQ9f9wovBoviUj_90gG29oLQ_m4OzYrulwROFlPmsIDRha-tfKBPwL2z7d4rmH3HasPzt3kG3e9waf-gU7S7asPU9dKOrZHl-H33x6hbPVsv4FBL8lI13Agt0Uxnbxm4hZ9W8amN5audACeDhbbyw8Dznd-tN65uqGm61D9DJlUjzIdqsm9o-RjEgV-dyrHKAkZiprFTAFkdyImXOXITSQXJC9wTmUEdjLkIgPStEJ23hpS2CtAWL0JvxnrOOvuPS3jswIWNPoN4OF5rFTPSWLLgqHOPWeByYUVVgWTinSuo0LyU2Oo_Q1jCdovcHrbjQ3gi9HJu9JUN4Rta2WYU-OdAoExqhR93sjyPxMAOQM4kQX9OLtaGut9TV98AWDudB88y_9-2gQRfD-r8onlz-FS_Qzcnx4YE42Dvaf4puEVBwSPOhW2hzuVjZZx6pLdXzYB4x-nbV9vgbA9hN8w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4k2gQJDgBFETx7GTA0KUsrQUKg5U2pvr57LSNimbXaH-NX4dM06y1fLordfYSZzxzOSzZ_wNIS-04xrWPiZRWVomYIkGbM6rRKG7RH47Htj2vxzyvSP2aVyMN8iv4SwMplUOPjE4atsY3CPfpoIyAXAbluq-T4v4ujt6e_ojwQpSGGkdyml0KnLgzn7C8q19s78Lc_2S0tGHb-_3kr7CQGIAqSwSbbmtFAYjuRFeCOWr1BeZ1aykyjqtmBOcs9SKFNRTY-wzM5lx0NWmprI5PPcKuSryIkMbE2Ox2t9B5vWSsf6cTpqX2y0LXimkz-clZQlf-xeGkgH_wrl_p2v-EbMNv8LRLXKzx7Dxu07pbpMNV98h17qqlmd3yUdQvXiyXMQnmOynXbwTGKGbqXVt7OdqMp1N21iduBnSAwDUjecOn-dh5d600DSt8VZ3jxxdijTvk826qd1DEiOK9b5IdYGQMuU6rzQyx9GCKlVwH5FskJw0PZk51tSYyRBUz0vZSVuCtGWQtuQRebW657Sj8riw9w5OyKon0nCHC818InurlkKXngtnARPmTJepKr3XFfNGVCq1pojI1jCdsvcNrTzX5Ig8XzWDVWOoRtWuWYY-BVIqUxaRB93sr0YCkANRNI2IWNOLtaGut9TT74E5HM-GFjm89_WgQefD-r8oHl38Fc_IdbBE-Xn_8OAxuUFRvzHjh22RzcV86Z4AaFvop8E6YnJ82eb4G6dQUik |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+gut+microbe+Bacteroides+fragilis+ameliorates+renal+fibrosis+in+mice&rft.jtitle=Nature+communications&rft.au=Zhou%2C+Wei&rft.au=Wu%2C+Wen-hui&rft.au=Si%2C+Zi-lin&rft.au=Liu%2C+Hui-ling&rft.date=2022-10-14&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2041-1723&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-022-33824-6&rft.externalDocID=10_1038_s41467_022_33824_6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |